salmeterol xinafoate has been researched along with Edema, Pulmonary in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (91.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandramoorthi, GD; Marimuthu, P; Piramanayagam, S | 1 |
| Boyle, S; Dunin-Bell, O | 1 |
| Auerbach, PS; Grissom, CK; Hackett, PH; Luks, AM; McIntosh, SE; Rodway, GW; Schoene, RB; Zafren, K | 1 |
| Cruden, NL; Newby, DE; Webb, DJ | 1 |
| Bärtsch, P; Mairbäurl, H | 1 |
| Fang, X; Frank, JA; Matthay, MA; McAuley, DF | 1 |
| Mutlu, GM; Sznajder, JI | 1 |
| Pandit, A | 1 |
| Fagenholz, PJ; Gutman, JA; Harris, NS; Murray, AF | 1 |
| Frank, JA; Matthay, MA; Osorio, O; Wang, Y | 1 |
| Voelkel, NF | 1 |
| Allemann, Y; Cook, S; Duplain, H; Egli, M; Hugli, O; Hutter, D; Lepori, M; Lipp, E; Nicod, P; Sartori, C; Scherrer, U; Turini, P | 1 |
1 trial(s) available for salmeterol xinafoate and Edema, Pulmonary
| Article | Year |
|---|---|
Salmeterol for the prevention of high-altitude pulmonary edema.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Altitude Sickness; Biological Transport, Active; Double-Blind Method; Epithelium; Female; Humans; Hypertension, Pulmonary; Hypoxia; Male; Membrane Potentials; Middle Aged; Nasal Mucosa; Pulmonary Alveoli; Pulmonary Edema; Salmeterol Xinafoate; Sodium | 2002 |
11 other study(ies) available for salmeterol xinafoate and Edema, Pulmonary
| Article | Year |
|---|---|
An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Altitude Sickness; Amino Acid Sequence; Binding Sites; Bronchodilator Agents; Computer Simulation; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Molecular Structure; Molecular Weight; Nifedipine; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Pulmonary Edema; Receptors, Adrenergic, beta-2; Reproducibility of Results; Salmeterol Xinafoate; Sequence Homology, Amino Acid; Spectrum Analysis, Raman; Vasodilator Agents | 2008 |
Secondary prevention of HAPE in a Mount Everest summiteer.
Topics: Acetazolamide; Adult; Albuterol; Altitude; Bronchodilator Agents; Diuretics; Humans; Male; Mountaineering; Piperazines; Pulmonary Edema; Purines; Salmeterol Xinafoate; Secondary Prevention; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2009 |
Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness.
Topics: Acetazolamide; Acute Disease; Albuterol; Altitude Sickness; Brain Edema; Carbolines; Dexamethasone; Humans; Mountaineering; Nifedipine; Piperazines; Pulmonary Edema; Purines; Salmeterol Xinafoate; Sildenafil Citrate; Societies; Sulfones; Tadalafil; Wilderness Medicine | 2010 |
Salmeterol for the prevention of high-altitude pulmonary edema.
Topics: Albuterol; Altitude Sickness; Biological Transport, Active; Epithelium; Hemodynamics; Humans; Nitric Oxide; Pulmonary Alveoli; Pulmonary Edema; Salmeterol Xinafoate; Sodium | 2002 |
Salmeterol for the prevention of high-altitude pulmonary edema.
Topics: Adrenergic beta-Agonists; Albuterol; Altitude Sickness; Blood Pressure; Bronchodilator Agents; Echocardiography, Doppler; Humans; Pulmonary Alveoli; Pulmonary Artery; Pulmonary Edema; Salmeterol Xinafoate; Sodium | 2002 |
Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury.
Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Albuterol; Animals; Extravascular Lung Water; Pulmonary Alveoli; Pulmonary Edema; Pulmonary Gas Exchange; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Salmeterol Xinafoate; Stereoisomerism | 2004 |
beta(2)-Agonists for treatment of pulmonary edema: ready for clinical studies?
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Humans; Pulmonary Alveoli; Pulmonary Edema; Rats; Respiratory Distress Syndrome; Salmeterol Xinafoate; Up-Regulation | 2004 |
The physiologic basis of high-altitude diseases.
Topics: Adrenergic beta-Agonists; Albuterol; Altitude Sickness; Animals; Extravascular Lung Water; Humans; Pulmonary Edema; Salmeterol Xinafoate | 2005 |
Treatment of high altitude pulmonary edema at 4240 m in Nepal.
Topics: Acetazolamide; Adult; Albuterol; Altitude; Altitude Sickness; Bed Rest; Emergency Treatment; Female; Humans; Male; Middle Aged; Mountaineering; Nepal; Nifedipine; Oxygen Inhalation Therapy; Piperazines; Pulmonary Edema; Purines; Salmeterol Xinafoate; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents | 2007 |
Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Atrial Function, Left; Bronchodilator Agents; Cattle; Hemodynamics; Humans; Lymph; Nebulizers and Vaporizers; Pulmonary Alveoli; Pulmonary Edema; Rats; Salmeterol Xinafoate; Serum Albumin, Bovine; Sheep | 2000 |
High-altitude pulmonary edema.
Topics: Adrenergic beta-Agonists; Albuterol; Altitude Sickness; Biological Transport, Active; Epithelium; Humans; Membrane Potentials; Pulmonary Alveoli; Pulmonary Edema; Salmeterol Xinafoate; Sodium | 2002 |